293 related articles for article (PubMed ID: 7515770)
21. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
Naume B; Gately M; Espevik T
J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
[TBL] [Abstract][Full Text] [Related]
22. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
[TBL] [Abstract][Full Text] [Related]
23. Immunologic effects in patients with psoriatic arthritis treated with cyclosporine A.
Boiardi L; Salvarani C; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Lodi L; Portioli I
J Rheumatol; 1992 Dec; 19(12):1933-7. PubMed ID: 1284133
[TBL] [Abstract][Full Text] [Related]
24. Relationship of large and small CD3- CD56+ lymphocytes mediating NK-associated activities.
Ortaldo JR; Winkler-Pickett R; Kopp W; Kawasaki A; Nagashima K; Okumura K; Yagita H; Bach FH
J Leukoc Biol; 1992 Sep; 52(3):287-95. PubMed ID: 1381742
[TBL] [Abstract][Full Text] [Related]
25. In vivo CD3+CD25+ lymphocyte subpopulation is down-regulated without increased serum-soluble interleukin-2 receptor (sIL-2R) by gonadotropin releasing hormone agonist (GnRH-a).
Ho HN; Wu MY; Chen HF; Chao KH; Yang YS; Huang SC; Lee TY; Gill TJ
Am J Reprod Immunol; 1995 Jan; 33(1):134-9. PubMed ID: 7619228
[TBL] [Abstract][Full Text] [Related]
26. Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56+ CD3- natural killer cells subset.
Garcia-Suarez J; Prieto A; Reyes E; Manzano L; Merino JL; Alvarez-Mon M
Blood; 1993 Sep; 82(5):1538-45. PubMed ID: 7689873
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression.
Richards SJ; Scott CS
Leuk Lymphoma; 1990; 2(1-2):111-26. PubMed ID: 27456578
[TBL] [Abstract][Full Text] [Related]
28. Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens.
Bradstock KF; Luxford C; Grimsley PG
Immunol Cell Biol; 1993 Dec; 71 ( Pt 6)():535-42. PubMed ID: 7508887
[TBL] [Abstract][Full Text] [Related]
29. Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.
Zupo S; Azzoni L; Massara R; D'Amato A; Perussia B; Ferrarini M
J Clin Immunol; 1993 May; 13(3):228-36. PubMed ID: 7686565
[TBL] [Abstract][Full Text] [Related]
30. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
[TBL] [Abstract][Full Text] [Related]
31. Normal expression of p55 interleukin 2 receptor (CD25) by lymphocytes from former blood donors seropositive for human T lymphotropic virus.
Prince HE; Jackson AL
Clin Immunol Immunopathol; 1990 Dec; 57(3):459-64. PubMed ID: 1700938
[TBL] [Abstract][Full Text] [Related]
32. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.
Rea IM; McNerlan SE; Alexander HD
Exp Gerontol; 1999 Jan; 34(1):79-93. PubMed ID: 10197730
[TBL] [Abstract][Full Text] [Related]
33. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets.
Nishikawa K; Saito S; Morii T; Kato Y; Narita N; Ichijo M; Ohashi Y; Takeshita T; Sugamura K
Int Immunol; 1990; 2(6):481-6. PubMed ID: 1707657
[TBL] [Abstract][Full Text] [Related]
35. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
36. Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimen.
Weiner LM; Hudes GR; Kitson J; Walczak J; Watts P; Litwin S; O'Dwyer PJ
Cancer Immunol Immunother; 1993; 36(3):185-90. PubMed ID: 8439979
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
[TBL] [Abstract][Full Text] [Related]
38. Cytofluorimetric analysis of mitogen-activated peripheral blood lymphocytes of non-leukemic lymphoma patients reveals an abnormal disease-related expression pattern of activation antigens.
Mangge H; Beaufort F; Kaulfersch W; Rossipal E; Schauenstein K
J Cancer Res Clin Oncol; 1990; 116(6):575-80. PubMed ID: 2174895
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic profiles of peripheral blood lymphocytes on the day of embryo transfer in women undergoing in vitro fertilization.
Baczkowski T; Kurzawa R
Folia Histochem Cytobiol; 2007; 45 Suppl 1():S73-7. PubMed ID: 18292839
[TBL] [Abstract][Full Text] [Related]
40. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome.
Morrison LJ; Behan WH; Behan PO
Clin Exp Immunol; 1991 Mar; 83(3):441-6. PubMed ID: 1706238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]